In the published article, there was an error in the order for Figure 7 and Figure 8 as published. The images from Figure 7 and Figure 8 were interchanged, while the Figure legends were in the right places. The corrected Figure 7 and Figure 8 appear below.
Figure 7
Figure 8
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
glioblastoma (GBM), primary cell line, patient-derived xenograft (PDX), fluorescence imaging, FLIM (fluorescence lifetime imaging microscopy)
Citation
Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D and Baklaushev V (2022) Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice. Front. Oncol. 12:1040637. doi: 10.3389/fonc.2022.1040637
Received
09 September 2022
Accepted
15 September 2022
Published
29 September 2022
Volume
12 - 2022
Edited and reviewed by
Ellen Ackerstaff, Memorial Sloan Kettering Cancer Center, United States
Updates
Copyright
© 2022 Yuzhakova, Kiseleva, Shirmanova, Shcheslavskiy, Sachkova, Snopova, Bederina, Lukina, Dudenkova, Yusubalieva, Belovezhets, Matvienko and Baklaushev.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Diana Yuzhakova, yuzhakova-diana@mail.ru; Vladislav Shcheslavskiy, vis@becker-hickl.de
†These authors have contributed equally to this work
This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.